Investment Summary

Morgan Stanley Capital Partners Invests In Code 3 Emergency Partners

On November 16, 2017, private equity firm Morgan Stanley Capital Partners invested in healthcare services company Code 3 Emergency Partners

Investment Highlights
  • This is Morgan Stanley Capital Partners’ 2nd transaction in the Healthcare Services sector.
  • This is Morgan Stanley Capital Partners’ 22nd transaction in the United States.
  • This is Morgan Stanley Capital Partners’ 4th transaction in Texas.

Investment Summary
Date 2017-11-16
Target Code 3 Emergency Partners
Sector Healthcare Services
Investor(s) Morgan Stanley Capital Partners
Deal Type Growth Capital
Advisor(s) Bailey & Company (Financial)

Target

Code 3 Emergency Partners

Frisco, Texas, United States
Code 3 Emergency Partners is a provider of freestanding emergency rooms and urgent care clinics. Code 3 Emergency Partners was founded in 2014 and is based in Frisco, Texas.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Morgan Stanley Capital Partners

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1985
Size Large
Type Sector Agnostic
DESCRIPTION

Morgan Stanley Capital Partners (MSCP) is the private investment arm of financial services firm and investment bank Morgan Stanley. MSCP looks to partner with founders looking to leverage Morgan Stanley's resources, as well as fund corporate carveouts, recapitalizations, buyouts, and industry consolidations. Areas of interest include business services, industrials, education, consumer products/services, food/beverage, retail, healthcare, and packaging. MSCP primarily targets businesses operating in North America valued between $75 and $750 million. Morgan Stanley Capital Partners is based in New York City.

DEAL STATS #
Overall 25 of 50
Sector (Healthcare Services) 2 of 3
Type (Growth Capital) 3 of 5
State (Texas) 4 of 8
Country (United States) 22 of 47
Year (2017) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-31 DiscoveRx

Fremont, California, United States

DiscoveRx Corp. is an innovative company that develops, manufactures, and commercializes reagents, complete cell-based assay kits, profiling and screening services as well as other disruptive solutions for the drug discovery, screening, and life science markets. EFC technology is a proven, established screening platform in most major pharmaceutical companies. With over 900 stable cell lines, 4500 drug discovery assays and kits, and both custom and off-the shelf services, DiscoverX is one of the most trusted and utilized drug discovery portfolios in the world.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-10 Manna Pro

Chesterfield, Missouri, United States

Manna Pro is a manufacturer and marketer of specialty pet care products, provides food, treats, and a wide assortment of high-quality health and wellness products for companion pets and hobby animals. Manna Pro has developed into an industry leader providing nutritionally wholesome products for dogs, cats, backyard chickens, and other companion pets. Manna Pron was formed in 1985 and is based in Chesterfield, Missouri.

Buy -
Mergr

Product

Company

Legal